!

URGENT: Big pharma is pushing legislation to give them more power to raise drug prices. Email your representative now. 

Trump's drug czar nominee withdraws after opioid report

October 17, 2017

President Trump announced Tuesday that his nominee for drug czar, Rep. Tom Marino, has withdrawn his name from consideration for the position. The announcement came following a joint investigation by CBS' "60 Minutes" and The Washington Post on the opioid crisis.

tommarino.jpeg

© AP Photo/Susan Walsh

The report found that Congress helped disarm the Drug Enforcement Administration during the height of the crisis. Marino, R-Pennsylvania, was the chief advocate for the bill at the center of the investigation.

The bill weakened the DEA's control over opioid drug distributors," reports CBS news.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Substance Abuse, A Mental Health Issue
The New Plan for Taking on Drug Pricing
Trump declares opioids a public health emergency

Featured Articles

Big Pharma’s Moral Low Ground
Take Action: Email Your Legislator to Stop Big Pharma’s Latest Price Gouging Move
Why do Pharmaceutical Companies hate PBMs so much?
Take Action: Email Your Legislator to Help Control Dialysis Costs
Podcast: NC Senator Ralph Hise Talks Surprise Billing and the Proposal to Stop it